BioSpace News Archive

Transparency Market Research has published a new report on the global vascular injury treatment market.

Transparency Market Research has published a new report titled, ‘Medical Tourism Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the medical device cleaning market was valued at ~US$ 2.8 Bn in 2018 and is expected to expand at a CAGR of ~5% during the forecast period.

Blood plasma and its derivatives form a significant source of medicines.

Seoul Viosys, the world’s first compound semiconductor for short wavelength solutions provider, announced that products with Violeds technology for perfectly clean laundry have been mass-produced and supplied to both Chinese two major makers, Hisense and Haier, which lead household washing machine products.

Gamida Cell Ltd. announced positive topline results from its Phase 3 clinical study evaluating the safety and efficacy of omidubicel, an investigational advanced cell therapy in development as a potential life-saving treatment option for patients in need of bone marrow transplant.

Zymo Research announced that the US Food and Drug Administration has approved its Quick SARS-CoV-2 rRT-PCR Kit for Emergency Use Authorization for the detection of SARS-CoV-2, the virus that causes COVID-19.

Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines, today presented preclinical data supporting its lead artificial antigen-presenting cell (aAPC) program, RTX-321, for the potential treatment of HPV 16-positive tumors at the American Society of Gene and Cell Therapy 23rd Annual Meeting. The meeting is being he

Marken announced that their Direct-to-Patient distribution services are now actively delivering to and from 94 cities in India and are expected to be available in 110 cities by the end of May.

Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today reported financial results and corporate highlights for the first quarter 2020, as well as anticipated corporate milestones for 2020. “I am pleased to report that Surface has made substantial clinical progress to date in 2020; achieving important milestones with both of our hig